Consensus guidelines for the use of empiric and diagnostic-driven antifungal treatment strategies in haematological malignancy, 2014-Reference-Cited by-同舟云学术

Consensus guidelines for the use of empiric and diagnostic-driven antifungal treatment strategies in haematological malignancy, 2014

Published:2014-12 Issue:12b Volume:44 Page:1298-1314
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Intern Med J

Author:

Morrissey C. O.¹²,Gilroy N. M.³⁴,Macesic N.⁵,Walker P.⁶⁷,Ananda-Rajah M.¹⁸,May M.⁹,Heath C. H.¹⁰¹¹,Grigg A.¹²¹³,Bardy P. G.¹⁴¹⁵¹⁶,Kwan J.¹⁷,Kirsa S. W.¹⁸,Slavin M.¹³¹⁹²⁰,Gottlieb T.²¹,Chen S.²²²³²⁴

Affiliation:

1. Department of Infectious Diseases; Alfred Health and Monash University; Prahran Victoria

2. Department of Clinical Haematology; Alfred Health; Prahran Victoria

3. Blood and Marrow Transplant (BMT) Network; Agency for Clinical Innovation; Chatswood New South Wales

4. Department of Infectious Diseases and Clinical Microbiology; St Vincent's Hospital; Darlinghurst New South Wales

5. Departmentof Infectious Diseases; Austin Health; Heidelberg Victoria

6. Malignant Haematology and Stem Cell Transplantation Service; Alfred Health; Prahran Victoria

7. Australian Centre for Blood Diseases; Monash University; Melbourne Victoria

8. Department of General Medicine; Alfred Health; Prahran Victoria

9. Department of Microbiology; Sullivan Nicolaides Pathology; Brisbane Queensland

10. Department of Microbiology and Infectious Diseases; Royal Perth Hospital; Perth Western Australia

11. School of Medicine and Pharmacology (RPH Unit); University of Western Australia; Perth Western Australia

12. Department of Clinical Haematology; Austin Health; Heidelberg Victoria

13. School of Medicine; The University of Melbourne; Melbourne Victoria

14. Royal Adelaide Hospital Cancer Centre; Royal Adelaide Hospital; Adelaide South Australia

15. Division of Medicine; The Queen Elizabeth Hospital; Woodville South South Australia

16. Discipline of Medicine; School of Medicine; The University of Adelaide; Adelaide South Australia

17. Department of Haematology and Bone Marrow Transplant; Westmead Hospital; Westmead New South Wales

18. Pharmacy Department; Peter MacCallum Cancer Centre; East Melbourne Victoria

19. Department of Infectious Diseases and Infection Control; Peter MacCallum Cancer Centre; East Melbourne Victoria

20. Victorian Infectious Diseases Service; The Doherty Institute for Infection and Immunity; Parkville Victoria

21. The Infectious Diseases and Microbiology Department; Concord Repatriation General Hospital; Concord New South Wales

22. Centre for Infectious Diseases and Microbiology Laboratory Services; ICPMR - Pathology West; Westmead New South Wales

23. Department of Infectious Diseases; Westmead Hospital; Westmead New South Wales

24. Sydney Medical School; The University of Sydney; Sydney New South Wales

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/imj.12596/fullpdf

Reference90 articles.

1. The spectrum of non-Candida fungal infections following bone marrow transplantation;Morrison;Medicine,1993

2. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis;Herbrecht;N Engl J Med,2002

3. Factors associated with overall and attributable mortality in invasive aspergillosis;Nivoix;Clin Infect Dis,2008

4. Impact of invasive fungal disease on the chemotherapy schedule and event-free survival in acute leukemia patients who survived fungal disease: a case-control study;Even;Haematologica,2011

5. The role of antifungal treatment in hematology;Maertens;Haematologica,2012

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of Risk Factors and Clinical Outcomes in Hospitalized COVID-19 Patients with Candida spp. Co-infections: Species Distribution and Antifungal Susceptibility Patterns of Isolates;Mycopathologia;2022-12-10

2. Survival Outcome of Empirical Antifungal Therapy and the Value of Early Initiation: A Review of the Last Decade;Journal of Fungi;2022-10-29

3. Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021;Internal Medicine Journal;2021-11

4. Introduction to the updated Australasian consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology/oncology setting, 2021;Internal Medicine Journal;2021-11

5. Effect of Therapeutic Drug Monitoring and Cytochrome P450 2C19 Genotyping on Clinical Outcomes of Voriconazole: A Systematic Review;Annals of Pharmacotherapy;2020-08-08